I
Invaio Sciences
Unlocking the potential of the planet’s interdependent natural systems to solve pressing agriculture, nutrition, and environmental challenges
About Invaio Sciences
Invaio is a pioneering startup that operates in the agricultural sector, aiming to revolutionize the way we approach crop health and pest control. The company's primary focus is on developing natural bioactives and innovative delivery systems to help farmers grow healthier and stronger crops. Invaio's approach is inspired by nature, using the science behind plants' natural systems to create effective and environmentally friendly solutions to crop challenges.
Read full description
Invaio serves a broad range of clients, primarily farmers and agricultural businesses, who are looking for more sustainable and effective ways to protect their crops from pests and diseases. The company operates in a market that is increasingly aware of the need for more sustainable farming practices, and it is well-positioned to meet this demand with its nature-inspired solutions.
The company's business model is based on research and development of new technologies and solutions for crop health. It generates revenue by selling these solutions to farmers and agricultural businesses. One of its major innovations is the precision delivery technology, which allows for more targeted and efficient application of crop protection solutions. This technology is the first major innovation in targeted delivery in crop protection for 25 years.
Invaio is also tackling specific crop diseases, such as Xylella in olives and citrus greening in oranges, offering hope to farmers whose livelihoods are threatened by these diseases. The company's approach to pest control, which is more nature-friendly than conventional methods, is expected to be a game-changer in the industry.
At a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Cambridge, United States
- Employees
- 88
- Open positions
- 2
- Dealroom signal
- 65.6/100
- Industry
- Food
- Sub-industry
- AgriTech
- Sector
- Food, Biotechnology, Precision Agriculture, Biopesticides, Sustainable Development Goals, Climate Tech, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 1 company, latest Dec 2023
- Capital deployed
- —
- Preferred round
- ACQUISITION
Latest news
Press, funding announcements and product moves mentioning Invaio Sciences.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Oct 2021 | $50M | — | K2 HealthVentures | — |
| SERIES COther financing | May 2021 | $89M | $356M | Alexandria Venture Investments · Flagship Pioneering · Bluwave Capital · Stage 1 Ventures | — |
Growth signals
Latest recorded traffic for Invaio Sciences is 3.6K monthly website visits, up 20% over the last three months. Invaio Sciences's team declined 22.1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Series B and later4 investors entered at this stage
Alexandria Venture Investments
Bluwave Capital
Stage 1 Ventures
K2 HealthVentures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Invaio Sciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Invaio Sciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.